Skip to content

T2 Biosystems, Inc.

CIK 0001492674

← back to feed
Revenue (TTM)
$7.47M
−67.8% YoY Q3 Nov 2024
Net Income (TTM)
−$48.04M
+19.2% YoY Q3 Nov 2024
EPS Diluted (TTM)
−$7.32
+98.4% YoY Q3 Nov 2024
Gross Margin
-181.3%
Q3 Nov 2024
Operating Margin
-615.0%
Q3 Nov 2024
Net Margin
-643.1%
Q3 Nov 2024
Free Cash Flow (TTM)
−$48.19M
Q3 Nov 2024
Cash
$2.08M
Q3 Nov 2024
Total Debt
—
Q3 Nov 2024
Shares Outstanding
21.04M sh
Q3 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings